Skip to main content

SeqWell: Dan Calvo

SeqWell, a Beverly, Massachusetts-based provider of next-generation sequencing library construction technologies, has named appointed Dan Calvo as president and CEO, effective April 19. Calvo most recently served as president and and CEO of Gyros Protein Technologies from 2013 through its acquisition by Mesa Labs in 2019. Prior to that, he was president and CEO of Oncimmune from 2009 to 2013. Calvo also previously served as CEO at Cellomics and Assay Designs, through their acquisitions by Fisher Scientific an Enzo Biochem, respectively.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.